skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Journal Title: Frontiers In Endocrinology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis
Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis
Material Type:
Article 		Add to My Research

Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis

Frontiers in endocrinology (Lausanne), 2021-08, Vol.12, p.706914-706914 [Peer Reviewed Journal]

Copyright © 2021 Zheng, Liu, Li, Shi, Zhang, Zhou and Su. ;Copyright © 2021 Zheng, Liu, Li, Shi, Zhang, Zhou and Su 2021 Zheng, Liu, Li, Shi, Zhang, Zhou and Su ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2021.706914 ;PMID: 34484120

Full text available

Citations Cited by
2
The effects of prebiotic, probiotic or synbiotic supplementation on overweight/obesity indicators: an umbrella review of the trials' meta-analyses
The effects of prebiotic, probiotic or synbiotic supplementation on overweight/obesity indicators: an umbrella review of the trials' meta-analyses
Material Type:
Article 		Add to My Research

The effects of prebiotic, probiotic or synbiotic supplementation on overweight/obesity indicators: an umbrella review of the trials' meta-analyses

Frontiers in endocrinology (Lausanne), 2024, Vol.15, p.1277921-1277921 [Peer Reviewed Journal]

Copyright © 2024 Rasaei, Heidari, Esmaeili, Khosravi, Baeeri, Tabatabaei-Malazy and Emamgholipour. ;Copyright © 2024 Rasaei, Heidari, Esmaeili, Khosravi, Baeeri, Tabatabaei-Malazy and Emamgholipour 2024 Rasaei, Heidari, Esmaeili, Khosravi, Baeeri, Tabatabaei-Malazy and Emamgholipour ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2024.1277921 ;PMID: 38572479

Full text available

Citations Cited by
3
Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6
Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6
Material Type:
Article 		Add to My Research

Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6

Frontiers in endocrinology (Lausanne), 2021-03, Vol.12, p.645566-645566 [Peer Reviewed Journal]

Copyright © 2021 Nauck and Quast. ;Copyright © 2021 Nauck and Quast 2021 Nauck and Quast ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2021.645566 ;PMID: 33854484

Full text available

Citations Cited by
4
Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials
Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials
Material Type:
Article 		Add to My Research

Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials

Frontiers in endocrinology (Lausanne), 2023-06, Vol.14, p.1132004-1132004 [Peer Reviewed Journal]

Copyright © 2023 Zhang, Hou, Li, Deng, Yang, Li, Yao, Yang, Lin, Liao, Wang, Liu, Tan, Wan and Shuai. ;Copyright © 2023 Zhang, Hou, Li, Deng, Yang, Li, Yao, Yang, Lin, Liao, Wang, Liu, Tan, Wan and Shuai 2023 Zhang, Hou, Li, Deng, Yang, Li, Yao, Yang, Lin, Liao, Wang, Liu, Tan, Wan and Shuai ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2023.1132004 ;PMID: 37455913

Full text available

Citations Cited by
5
The Effect of Orlistat on Sterol Metabolism in Obese Patients
The Effect of Orlistat on Sterol Metabolism in Obese Patients
Material Type:
Article 		Add to My Research

The Effect of Orlistat on Sterol Metabolism in Obese Patients

Frontiers in endocrinology (Lausanne), 2022-02, Vol.13, p.824269-824269 [Peer Reviewed Journal]

Copyright © 2022 Kwon, Kwon, Lee, Choi and Lee. ;Copyright © 2022 Kwon, Kwon, Lee, Choi and Lee 2022 Kwon, Kwon, Lee, Choi and Lee ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2022.824269 ;PMID: 35282441

Full text available

Citations Cited by
6
Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women
Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women
Material Type:
Article 		Add to My Research

Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women

Frontiers in endocrinology (Lausanne), 2021-11, Vol.12, p.742873-742873 [Peer Reviewed Journal]

Copyright © 2021 Rodgers, Migdal, Rodríguez, Chen, Nath, Gerszten, Kasid, Toschi, Tripaldi, Heineman, Phan, Ngo, Maratos-Flier and Dushay. ;Copyright © 2021 Rodgers, Migdal, Rodríguez, Chen, Nath, Gerszten, Kasid, Toschi, Tripaldi, Heineman, Phan, Ngo, Maratos-Flier and Dushay 2021 Rodgers, Migdal, Rodríguez, Chen, Nath, Gerszten, Kasid, Toschi, Tripaldi, Heineman, Phan, Ngo, Maratos-Flier and Dushay ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2021.742873 ;PMID: 34867786

Full text available

Citations Cited by
7
Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial
Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial
Material Type:
Article 		Add to My Research

Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial

Frontiers in endocrinology (Lausanne), 2023-01, Vol.14, p.1106868-1106868 [Peer Reviewed Journal]

Copyright © 2023 Cai, Chen, Duan, Zhao and Zhang. ;Copyright © 2023 Cai, Chen, Duan, Zhao and Zhang 2023 Cai, Chen, Duan, Zhao and Zhang ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2023.1106868 ;PMID: 36777344

Full text available

Citations Cited by
8
Protocol for a randomized placebo-controlled clinical trial using pure palmitoleic acid to ameliorate insulin resistance and lipogenesis in overweight and obese subjects with prediabetes
Protocol for a randomized placebo-controlled clinical trial using pure palmitoleic acid to ameliorate insulin resistance and lipogenesis in overweight and obese subjects with prediabetes
Material Type:
Article 		Add to My Research

Protocol for a randomized placebo-controlled clinical trial using pure palmitoleic acid to ameliorate insulin resistance and lipogenesis in overweight and obese subjects with prediabetes

Frontiers in endocrinology (Lausanne), 2023, Vol.14, p.1306528-1306528 [Peer Reviewed Journal]

Copyright © 2024 Cetin, Pedersen, Porter, Adler and Burak. ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2023.1306528 ;PMID: 38313838

Full text available

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait